Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis
Nicoll Matthews, F. Zeng, Kirsty Hodgson, Matthew Fisher, Ziqian Peng, Libby Blencoe, Margarita Orozco‐Moreno, Ella P. Dennis, Liancheng Lu, Michelle Anne Lawson, Shenglin Mei, David B. Sykes, Dallas B. Flies, Richard Beatson, Ning Wang, Jennifer Munkley
Siglec-15 is found on prostate tumour cells, macrophages and osteoclasts; antibody blockade reduced macrophage immunosuppression, osteoclast formation and tumour growth in mice (CD8+ T-cell-dependent).
bioRxiv · Aug 10, 2026 · PreprintCancer Biology✦ In-depth digest